EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Reappraisal of Blood Markers in Sudden Sensorineural Hearing Loss Using a Single-Center OMOP Common Data Model: Associations with Onset, Baseline Severity, and Recovery Across Clinical Axes and Sampling Timings

Chul Young Yoon, SongYi Kim, Jin Su Kim, Seungmi Im, Yeon Ho Seo, Dam Yoon, Young Joon Seo

Diagnostics · 18.11.2026 · 16 (22) · 3843

DOI: 10.3390/diagnostics16223843 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Diagnostics, online erschienen am 18.11.2026. Verfasst von Chul Young Yoon und 6 weiteren Autor:innen. Die Arbeit nennt 38 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Research Foundation of Korea, Commercialization Promotion Agency for R&D Outcomes, Korea Evaluation Institute of Industrial Technology.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background/Objectives: This study aimed to reappraise the practice of treating admission-day blood values as a fixed baseline in sudden sensorineural hearing loss (SSNHL). Blood markers were grouped into clinical axes A (acute cellular stress), B (reserve/protein), and C (acute-phase response) and tested for associations with onset, baseline pure-tone average (PTA), and recovery at timings E0, Eb, and Δ.

Methods

First SSNHL episodes were identified in a single-center OMOP CDM (n = 5311; 2002–2025). Markers were classified into three clinical axes (A/B/C), and sampling timing was separated into E0, Eb, and Δ. Prespecified hypotheses were H1 (onset OR for Eb 36-month NLR, TP, and Glb), H2 (E0 albumin–PTA), and H3 (E0 CAR–PTA). Onset used 1:4 age–sex matched odds ratios; PTA used linear regression; recovery used logistic regression. Exploratory analyses were controlled with Benjamini–Hochberg FDR. Recovery sensitivity definitions and indication-stratified rematching were applied.

Results

Under H1, onset ORs were NLR 1.05 (1.03–1.07), TP 0.81 (0.73–0.90), and Glb 0.83 (0.73–0.95). Under H2, E0 albumin–PTA β was −12.94 (−17.49 to −8.40; q < 0.001). Under H3, E0 CAR–PTA β was 6.88 (1.61–12.15; q = 0.039). E0 NLR was unrelated to PTA. Recovery remained null after definition diversification and FDR. After indication-stratified rematching, the NLR onset OR and E0 albumin/CAR–PTA signals were retained.

Conclusions

SSNHL blood markers should be reported by clinical axis (A/B/C) and sampling timing (E0/Eb/Δ). Onset and baseline-severity signals persist after indication adjustment, whereas evidence for recovery prediction remains weak.

Förderung

  • National Research Foundation of Korea
  • Commercialization Promotion Agency for R&D Outcomes
  • Korea Evaluation Institute of Industrial Technology
  • KRISS
  • Ministry of Education

Zitieren

APA

Yoon, C. Y., Kim, S., Kim, J. S., Im, S., Seo, Y. H., Yoon, D., & Seo, Y. J. (2026). Reappraisal of Blood Markers in Sudden Sensorineural Hearing Loss Using a Single-Center OMOP Common Data Model: Associations with Onset, Baseline Severity, and Recovery Across Clinical Axes and Sampling Timings. Diagnostics, 16(22), 3843. https://doi.org/10.3390/diagnostics16223843

Vancouver

Yoon CY, Kim S, Kim JS, Im S, Seo YH, Yoon D, et al. Reappraisal of Blood Markers in Sudden Sensorineural Hearing Loss Using a Single-Center OMOP Common Data Model: Associations with Onset, Baseline Severity, and Recovery Across Clinical Axes and Sampling Timings. Diagnostics. 2026;16(22):3843. doi:10.3390/diagnostics16223843

BibTeX
@article{Yoon2026,
  author = {Yoon, Chul Young and Kim, SongYi and Kim, Jin Su and Im, Seungmi and Seo, Yeon Ho and Yoon, Dam and Seo, Young Joon},
  title = {Reappraisal of Blood Markers in Sudden Sensorineural Hearing Loss Using a Single-Center OMOP Common Data Model: Associations with Onset, Baseline Severity, and Recovery Across Clinical Axes and Sampling Timings},
  journal = {Diagnostics},
  year = {2026},
  volume = {16},
  number = {22},
  pages = {3843},
  doi = {10.3390/diagnostics16223843}
}
Kostenlos starten →